Newly detected diabetes during the COVID-19 pandemic: What have we learnt?

Hirani, Dhruti; Salem, Victoria; Khunti, Kamlesh; Misra, Shivani

Hirani, Dhruti; Salem, Victoria; Khunti, Kamlesh; Misra, Shivani.

Afiliação

Hirani D; Diabetes, Endocrinology And Metabolism, Imperial College Healthcare NHS Trust, UK.
Salem V; Diabetes, Endocrinology And Metabolism, Imperial College Healthcare NHS Trust, UK; Department of Bioengineering, Faculty of Engineering, Imperial College London, London, UK.
Khunti K; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.
Misra S; Diabetes, Endocrinology And Metabolism, Imperial College Healthcare NHS Trust, UK; Division of Metabolism, Digestion & Reproduction, Faculty of Medicine, Imperial College London, London, UK. Electronic address: s.misra@imperial.ac.uk.

Best Pract Res Clin Endocrinol Metab ; 37(4): 101793, 2023 07.

Article em En | MEDLINE | ID: mdl-37468405

Assuntos

COVID-19; Diabetes Mellitus Tipo 1; Diabetes Mellitus Tipo 2; Criança; Humanos; COVID-19/epidemiologia; SARS-CoV-2; Pandemias; Diabetes Mellitus Tipo 2/epidemiologia; Diabetes Mellitus Tipo 1/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / COVID-19 Limite: Child / Humans Idioma: En Revista: Best Pract Res Clin Endocrinol Metab Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google